AstraZeneca
AZN
#48
Rank
NZ$497.23 B
Marketcap
NZ$320.74
Share price
3.14%
Change (1 day)
29.58%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: NZ$497.23 Billion

As of February 2026 AstraZeneca has a market cap of NZ$497.23 Billion. This makes AstraZeneca the world's 48th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$497.23 B0.03%
2025NZ$497.06 B37.68%
2024NZ$361.02 B9.15%
2023NZ$330.76 B-0.18%
2022NZ$331.37 B24.73%
2021NZ$265.67 B46.35%
2020NZ$181.53 B-6.58%
2019NZ$194.32 B38.05%
2018NZ$140.76 B14.74%
2017NZ$122.67 B23.22%
2016NZ$99.56 B-21.19%
2015NZ$126.32 B10.51%
2014NZ$114.30 B26.76%
2013NZ$90.17 B26.54%
2012NZ$71.25 B-8.12%
2011NZ$77.55 B-8.06%
2010NZ$84.36 B-10.04%
2009NZ$93.77 B-8.37%
2008NZ$102.34 B25.65%
2007NZ$81.44 B-30.05%
2006NZ$116.44 B1.97%
2005NZ$114.19 B36.2%
2004NZ$83.84 B-33.46%
2003NZ$126.00 B9.34%
2002NZ$115.23 B-41.17%
2001NZ$195.86 B-4.57%
2000NZ$205.23 B44.65%
1999NZ$141.88 B75.41%
1998NZ$80.88 B37.38%
1997NZ$58.87 B56.84%
1996NZ$37.54 B

End of Day market cap according to different sources

On Feb 7th, 2026 the market cap of AstraZeneca was reported to be:

NZ$994.75 Billion
by Nasdaq info icon info icon
NZ$497.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$960.74 B 93.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$502.41 B 1.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$257.15 B-48.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$320.51 B-35.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.576 T 217.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$193.03 B-61.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$49.03 B-90.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$506.04 B 1.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$209.68 B-57.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$200.82 B-59.61%๐Ÿ‡ฌ๐Ÿ‡ง UK